What monitoring and follow‑up should be performed after a therapeutic or diagnostic paracentesis?

Monitoring After Paracentesis

After paracentesis, monitor vital signs (particularly blood pressure) and observe the puncture site for bleeding or hematoma formation, with heightened vigilance for the first 24 hours when hemorrhagic complications most commonly manifest. 1

Immediate Post-Procedure Monitoring

Vital Signs and Clinical Assessment

• Monitor blood pressure and heart rate closely for signs of hypotension or circulatory dysfunction
• Observe the puncture site for bleeding, hematoma formation, or ecchymosis
• Assess for abdominal pain or distention that could indicate intraperitoneal hemorrhage
• Monitor for signs of hypovolemia, particularly after large-volume paracentesis (>5L)

Critical pitfall: Intraperitoneal hemorrhage from abdominal wall artery injury (inferior epigastric or deep circumflex iliac artery) may present as occult bleeding with delayed hypotension up to 24 hours post-procedure, even without overt abdominal signs 2, 3. A high index of suspicion is required for unexplained hypotension post-paracentesis.

Volume-Specific Considerations

For large-volume paracentesis (>5L):

• Administer 8g albumin per liter of ascites removed as 20-25% solution after completion 1
• This is a strong recommendation with high-quality evidence to prevent post-paracentesis circulatory dysfunction and acute kidney injury

For smaller volumes (<5L):

• Albumin administration can be considered in patients with:
  • Acute-on-chronic liver failure (ACLF)
  • Pre-existing hypotension
  • Renal insufficiency
  • Electrolyte abnormalities 4

Laboratory Monitoring

Renal Function

• Monitor serum creatinine for development of acute kidney injury, particularly in patients with:
  • Large-volume paracentesis
  • Pre-existing renal dysfunction
  • Concurrent spontaneous bacterial peritonitis (SBP)

Electrolyte Surveillance

• Check serum sodium if patient is on diuretics or has baseline hyponatremia
• Monitor for post-paracentesis circulatory dysfunction, which can precipitate renal impairment

Follow-Up Care

Maintenance Therapy

After therapeutic paracentesis, patients require ongoing management 5:

• Continue or initiate diuretic therapy (spironolactone ± furosemide) to prevent rapid reaccumulation
• Maintain dietary sodium restriction (≤5g salt/day)
• Monitor weight, urine output, and electrolytes during diuretic titration 1

When to Repeat Paracentesis

For diagnostic purposes:

• If SBP is suspected or diagnosed, consider repeat paracentesis at 48 hours to assess treatment response if clinical improvement is inadequate or secondary peritonitis is suspected 6
• A decrease in polymorphonuclear count <25% from baseline indicates treatment failure

For therapeutic purposes:

• Frequency guided by symptom recurrence in refractory ascites 4

Special Populations Requiring Enhanced Monitoring

Patients on Anticoagulation

• Discontinue anticoagulation if hemorrhagic complications develop 3
• Note: INR is neither a reliable predictor of bleeding risk nor an indication to withhold paracentesis in cirrhotic patients 1, 3

Patients with SBP

• Monitor closely for hepatorenal syndrome development
• Patients with elevated creatinine or bilirubin at SBP diagnosis benefit most from albumin administration (1.5g/kg at diagnosis, 1g/kg on day 3) 1, 6

Red Flags Requiring Urgent Evaluation

Seek immediate evaluation if patient develops:

• Unexplained hypotension (even without abdominal signs)
• New or worsening abdominal pain
• Ecchymosis at puncture site
• Progressive lethargy or confusion
• Oliguria or rising creatinine

These may indicate intraperitoneal hemorrhage requiring CT angiography and potential angioembolization 2, 7, 8.

Transplant Referral

Development of ascites requiring paracentesis should prompt expedited liver transplantation evaluation, as this represents a critical milestone in cirrhosis progression 9, 10.